EVOGENE LTD.
EVGNEvogene Ltd. is an Israeli biotechnology company specializing in genetic and computational biology to develop new products in agriculture, food, and health sectors. The company leverages advanced genomic and bioinformatic technologies to create improved crops, bio-materials, and other biotechnological solutions.
Company News
The plant genotyping equipment market is experiencing significant growth due to advancements in sequencing technologies and increasing demand for high-yield, stress-tolerant crops. The market is expected to reach $1662.43 million by 2032, driven by the need for efficient, high-yield crop production methods.
The global agricultural biotechnology market is expected to grow from USD 121.24 billion in 2023 to USD 268.32 billion by 2033, driven by increasing demand for sustainable agriculture and food security.
Evogene (EVGN) delivered earnings and revenue surprises of 7.14% and 66.59%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Mirum Pharmaceuticals, Inc. (MIRM) delivered earnings and revenue surprises of -94.12% and 4.23%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 21.05% and 97.18%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
